Mereo BioPharma

Quick facts

Phase 2 pipeline

• Alvelestat oral tablet - dose 1 · Respiratory
  Alvelestat is a selective inhibitor of neutrophil elastase, an enzyme involved in the degradation of lung tissue.
• BCT197

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Mereo BioPharma portfolio CI brief
• Mereo BioPharma pipeline updates RSS